The Intellectual Property Law Association of Chicago (IPLAC) Patent Committee will be hosting a presentation by Professor R. Carl Moy of the Mitchell Hamline School of Law, entitled "Cuozzo Speed Technologies-Broadest Reasonable Interpretation: A Nonsensical Scenario" on June 7, 2016 from 4:30 to 5:30 pm (Central) at Fitch, Even, Tabin, & Flannery LLP in Chicago, IL. Prof. Moy will provide his comments and insights on the Cuozzo Speed Technologies case that was recently argued at the U.S. Supreme Court. A reception will follow the presentation. The registration fee for the event is $20 (IPLAC members), $30 (non-members), and $5 (students). Those interested in registering for event can do so by here.
Contributors
Juristat #4 Overall Rank
Contact the Docs
Foreign Correspondents
Recent Posts
- Enough is (Apparently) Enough - Part IV
- Enough is (Apparently) Enough - Part III
- Enough is (Apparently) Enough - Part II
- Season's Greetings from Patent Docs
- Enough is (Apparently) Enough - Part I
- Judge Newman Files Appeal with D.C. Circuit
- Yes, Patent Center Really is that Bad
- An American (and Entirely Unnecessary) Tragedy
- USPTO Drops Proposal to Change Terminal Disclaimer Practice
- USPTO Institutes Additional Fees for Large Information Disclosure Statement Filings
Disclaimer
- "Patent Docs" does not contain any legal advice whatsoever. This weblog is for informational purposes only, and its publication does not create an attorney-client relationship. In addition, nothing on "Patent Docs" constitutes a solicitation for business. This weblog is intended primarily for other attorneys. Moreover, "Patent Docs" is the personal weblog of the Authors; it is not edited by the Authors' employers or clients and, as such, no part of this weblog may be so attributed. All posts on "Patent Docs" should be double-checked for their accuracy and current applicability.
Juristat #8 Overall Rank
- Powered By Invesp
« IPLAC Trade Secrets Seminar | Main | Conference & CLE Calendar »
June 04, 2016
The comments to this entry are closed.
January 2025
Categories
- Artificial Intelligence (19)
- Best Mode (2)
- Biosimilars (247)
- Biotech/Pharma Business (175)
- Biotech/Pharma News (277)
- Board of Patent Appeals and Interferences (12)
- Claim Construction (104)
- Conferences & CLE's (2977)
- Copyright (4)
- Court Report (507)
- Damages (37)
- Definiteness (27)
- District Court (223)
- Double Patenting (40)
- Enablement (52)
- Federal Circuit (1025)
- Food and Drug Administration (112)
- Hatch-Waxman (96)
- Inequitable Conduct (52)
- Infringement - Contributory or Induced (28)
- Infringement - Literal or DOE (91)
- Injunction (37)
- International IP (297)
- Inventorship (17)
- Licensing (129)
- Media Commentary (71)
- Miscellaneous (169)
- News from Abroad (102)
- Novelty (73)
- Obviousness (233)
- Patent Exhaustion (3)
- Patent Legislation (312)
- Patent Litigation (217)
- Patent Office Rules & Procedures (831)
- Patent Profiles (104)
- Patent Prosecution (99)
- Patent Prosecution - International (26)
- Patent Research (4)
- Patent Trial and Appeal Board (369)
- Patentable Subject Matter (644)
- Personalized Medicine (5)
- Post-Grant Proceedings (158)
- PTAB Report (9)
- Study/Report (7)
- Supreme Court (265)
- Tools (5)
- Trade Secrets (13)
- Utility (4)
- Venue (11)
- Written Description (88)
Patent Resources
Patent Search
- Patent Search
Patent Blogs & Sites
- 717 Madison Place
- America-Israel Patent Law
- Anticipate This!
- BlawgIT
- Chicago IP Litigation Blog
- FedCircuitBlog
- Global Patent Quality
- Innovation Alliance
- Intellectual Property Watch
- IP Dragon
- IPcopy
- McCabe Ali LLP
- IPWatchdog.com
- Life Science IP
- Orange Book Blog
- Patent Blurb
- Patently-O
- Patentology
- Patents4Life
- Reexamination Center
- Intellepedia – IP News Center
- SPICY IP
Comments